This session through an interactive case study format will engage the participants in examining the updated 2012 AGS Beers Criteria. The discussion will focus on minimizing or eliminating potentially inappropriate medications (PIMs) and exploring alternative pharmacotherapeutic strategies in selected therapeutic areas.
The overall goal of this session is to ultimately enhance participants’ knowledge and competency in the safety of prescribing medications in older adults and how to effectively use The Beers List criteria.
Upon completion of this session, attendees should be able to:
Evaluate the necessity and the potential for inappropriate use of the newer anticoagulants as compared to warfarin in older patients with an emphasis on individualized risk-benefit assessment.
Explain the pros and cons of various psychoactive medications within the context of PIMS in the Beers List.
Select appropriate agents to manage heart failure in the long term setting from the perspective of the guidelines in a frail, older long term care resident.
Describe a patient-centered approach to diabetes management and how to eliminate inappropriate medications (including sliding-scale insulin) and improve glycemic control.
The American Medical Directors Association (AMDA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American Medical Directors Association designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AMDCP Credit Designation:
This session has been approved for a total of clinical 1.5 credit hours toward certification as a Certified Medical Director in Long Term Care (CMD).
AGS GERIATRICS RECOGNITION AWARD
This CME activity is endorsed by the American Geriatrics Society. Credits earned from this activity may be counted toward the AGS Geriatrics Recognition Award.